Startseite Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection

  • May Young Lin und Tom H.M. Ottenhoff
Veröffentlicht/Copyright: 27. März 2008
Biological Chemistry
Aus der Zeitschrift Band 389 Heft 5

Abstract

Mycobacterium tuberculosis is one of the worlds' most successful and sophisticated pathogens. It is estimated that over 2 billion people today harbour latent M. tuberculosis infection without any clinical symptoms. As most new cases of active tuberculosis (TB) arise from this (growing) number of latently infected individuals, urgent measures to control TB reactivation are required, including post-exposure/therapeutic vaccines. The current bacille Calmette-Guérin (BCG) vaccine and all new generation TB vaccines being developed and tested are essentially designed as prophylactic vaccines. Unfortunately, these vaccines are unlikely to be effective in individuals already latently infected with M. tuberculosis. Here, we argue that detailed analysis of M. tuberculosis genes that are switched on predominantly during latent stage infection may lead to the identification of new antigenic targets for anti-TB strategies. We will describe essential host-pathogen interactions in TB with particular emphasis on TB latency and persistent infection. Subsequently, we will focus on novel groups of late-stage specific genes, encoded amongst others by the M. tuberculosis dormancy (dosR) regulon, and summarise recent studies describing human T-cell recognition of these dormancy antigens in relation to (latent) M. tuberculosis infection. We will discuss the possible relevance of these new classes of antigens for vaccine development against TB.


Corresponding author

Published Online: 2008-03-27
Published in Print: 2008-05-01

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Guest Editorial
  2. Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
  3. Highlight: 3rd Semmering Conference 2007
  4. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
  5. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
  6. Novel strategies to identify biomarkers in tuberculosis
  7. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
  8. Lipopolysaccharide: a tool and target in enterobacterial vaccine development
  9. The coming of age of virus-like particle vaccines
  10. Maintenance of serological memory
  11. Adjuvant activity of type I interferons
  12. Japanese encephalitis vaccines – needs, flaws and achievements
  13. Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
  14. Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
  15. Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
  16. Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
  17. Review
  18. RNA switches regulate initiation of translation in bacteria
  19. Protein Structure and Function
  20. Inhibition of bacterial oxidases by formamide and analogs
  21. Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus
Heruntergeladen am 11.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/BC.2008.057/html
Button zum nach oben scrollen